IDIVAL launches the second programme of sessions Valdecilla Progress Report as part of its talent development and knowledge exchange program. In this program, young researchers from the clinical field and IDIVAL's laboratories present scientific advances in their current research projects. These sessions are intended to encourage discussion and networking among the researchers and doctors and to add value to the work being carried out. Speakers will be predoctoral contracts, researchers Post-MIR Valdecilla López Albo, etc. They will present these sessions with the presence of their corresponding project directors.
This year all the sessions will be monthly and will have two speakers who will present their progress and lines of work. Each speaker will talk about 15 minutes followed by a small debate and at the end, coffee will be served to continue the conversation and encourage interaction between participants and attendees.
All sessions will take place at 2:00 pm in Pavilion 16 of the Marqués de Valdecilla University Hospital (maximum capacity of 30 people). In addition, certificates of attendance will be issued if 80% of the sessions are attended throughout the academic period, and participation in them will be taken into account within the doctoral program.
On November 15, the first session will be given by David San Segundo Arribas, a specialist in Immunology and member of the IDIVAL research group on Autoimmunity and Transplantation, who will talk about “Myeloid-derived suppressor cells (MDSC) and immunoregulation in transplantation” and María Juncal Ruíz, child psychiatrist at Sierrallana Hospital and researcher in the program of first episodes of psychosis (PAFIP) of the University Hospital Marqués de Valdecilla and PhD student at the University of Cantabria, which will focus its session on the “systemic immunoinflammatory response in patients with a first psychotic episode”.
We encourage all the researchers and young specialists to attend on Wednesday, November 15 at 2:00 p.m. in room 2-3 of Hall 16 HUMV.
